2024 IAS-USA Guidelines Virtual Update: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

When and What To Start
Lead: Huldrych F. Günthard, MD
Panelists: Roger Bedimo, MD, Carlos del Rio, MD, Rajesh Gandhi, MD, Raphael Landovitz, MD, Clara Lehmann, MD, and Sandra Springer, MD
Co-Infections in the Setting of ART: TB, OIs, and Others
Lead: Brenda Crabtree, MD
Panelists: Roger Bedimo, MD, Carlos del Rio, MD, Rajesh Gandhi, MD, Huldrych F. Günthard, MD, Clara Lehmann, MD, and Sandra Springer, MD
Substance Use Disorder and HIV
Lead: Sandra Springer, MD
Panelists: Roger Bedimo, MD, Carlos del Rio, MD, Rajesh Gandhi, MD, Huldrych F. Günthard, MD, Brenda Crabtree, MD, Michael Saag, MD, and Clara Lehmann, MD
When and How To Switch
Lead: Rajesh Gandhi, MD
Panelists: Roger Bedimo, MD, Carlos del Rio, MD, Huldrych F. Günthard, MD, Brenda Crabtree, MD, Jennifer Hoy, MBBS, Michael Saag, MD, Jean-Michael Molina, MD, David Smith, MD, and Sandra Springer, MD
Comorbidities in the Setting of ART: Focus on Cardiovascular Disease, Statins, and Weight Management
Lead(s): Melanie A. Thompson, MD, and Roger Bedimo, MD
Panelists: Carlos del Rio, MD, Rajesh Gandhi, MD, Huldrych F. Günthard, MD, Jennifer Hoy, MBBS, Michael Saag, MD, David Smith, MD, and Sandra Springer, MD
HIV Prevention and STI Prevention
Lead: Raphael J. Landovitz, MD
Panelists: Roger Bedimo, MD, Susan Buchbinder, MD, Carlos del Rio, MD, Rajesh Gandhi, MD, Huldrych F. Günthard, MD, Jean-Michael Molina, MD, Michael Saag, MD, David Smith, MD, and Sandra Springer, MD